Zobrazeno 1 - 10
of 526
pro vyhledávání: '"Petrucci, MT"'
Autor:
O. Annibali, Fazio F, Di Cecca M, Liberatore C, Pisani F, De Padua L, Tomarchio V, Poggiali R, Fioritoni F, Tafuri MT, Viola F, Montanaro G, Passucci M, Pulini S, Petrucci MT, Rigacci L
Publikováno v:
HemaSphere, Vol 7, Iss S2, Pp 44-44 (2023)
Externí odkaz:
https://doaj.org/article/f10e68f7a4ff44f6a7e697e1fbe7c730
Publikováno v:
Blood and Lymphatic Cancer: Targets and Therapy, Vol 2016, Iss Issue 1, Pp 37-47 (2016)
Sara Grammatico, Laura Cesini, Maria Teresa Petrucci Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy Abstract: Peripheral neuropathy is one of the most important complications of multipl
Externí odkaz:
https://doaj.org/article/cf281389a70047ca822d9d53123f61dc
Publikováno v:
Patient Preference and Adherence, Vol 2014, Iss default, Pp 939-946 (2014)
Maria Teresa Petrucci, Paola Finsinger, Marta Chisini, Fabiana GentiliniDepartment of Cellular Biotechnology and Hematology, Sapienza University of Rome, ItalyAbstract: The use of novel agents such as thalidomide, lenalidomide, and bortezomib has con
Externí odkaz:
https://doaj.org/article/e36668a9530742c196d655586bae089b
Autor:
Fazio, F, Franceschini, L, Tomarchio, V, Rago, A, Garzia, Mg, Cupelli, L, Bongarzoni, V, Andriani, A, Gumenyuk, S, Tafuri, A, Siniscalchi, A, Piciocchi, A, De Fabritiis, P, De Rosa, L, Caravita di Toritto, T, Annibali, O, Cantonetti, M, Petrucci, Mt
Publikováno v:
EJHaem. 3(1)
The multiple myeloma (MM) treatment has changed over the last years due to the introduction of novel drugs. Despite improvements in the MM outcome, MM remains an incurable disease. Daratumumab is a human IgGK monoclonal antibody targeting CD38 with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09abf85a7f3a1a14ec6d374b2610570d
https://pubmed.ncbi.nlm.nih.gov/35846211
https://pubmed.ncbi.nlm.nih.gov/35846211
This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). Relapsed and refractory multiple myeloma pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::678600d0e3b35d73db4cf0d73b19424a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085585
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085585
Autor:
San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Mateos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG, VISTA Trial Investigators, Cavo M
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
12 páginas, 2 figuras, 3 tablas.-- Presented in part at the annual meeting of the American Society of Hematology, Atlanta, December 10, 2007.-- et al.
[Background]: The standard treatment for patients with multiple myeloma who are not candidate
[Background]: The standard treatment for patients with multiple myeloma who are not candidate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d79a57f22c587089a03af27a01e854
https://doi.org/10.1056/nejmoa0801479
https://doi.org/10.1056/nejmoa0801479
Autor:
Cavo, M, Corradini, P, DI RAIMONDO, Francesco, Vacca, A, Petrini, M, Cafro, Am, di Toritto TC, Offidani, M, Semenzato, G, Zambello, R, Lazzaro, A, Patriarca, F, Petrucci, Mt, Rodeghiero, F, Simcock, M, Slaughter, A, Herring, J, Peluso, T, Palumbo, A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::4e0a504746771f4dd0958ac47d2cd24a
http://hdl.handle.net/20.500.11769/47578
http://hdl.handle.net/20.500.11769/47578
Publikováno v:
HemaSphere; May2023 Supplement S2, Vol. 7, p45-46, 2p